Srinagarind Hospital Eye Clinic
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
NCT Number: NCT00501878
To compare the clinical efficacy and systemic side effects between 2.5% and 10% phenylephrine for mydriasis in diabetic patient with darkly pigmented irides.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
One hundred patients with diabetes from Srinagarind Hospital Eye Clinic were enrolled and randomized into two groups by block randomization. In group I (50 patients), 1% tropicamide combined with 2.5% phenylephrine were administered to dilate pupil whereas 1% tropicamide combined with 10% phenylephrine were used in Group II (50 patients). Pupil diameter, blood pressure and heart rate were measured before and after eye drop instillations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: before and after phenylephrine eye drop instillations
Time frame: before and after phenylephrine eye drop instillations
Looking for future studies?
Notify MeKhon Kaen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02821117
Diabetes Mellitus, Endocrine System Diseases
Hanover, Germany
View Trial DetailsNCT05186389
Body Weight, Diabetes Mellitus
Paris, France
View Trial DetailsNCT02593032
Cardiovascular Diseases, Diabetes Mellitus
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06186245
Acid-Base Imbalance, Acidosis
Lubbock, Texas, United States
View Trial Details